1. Lee EJ, Kwon SY, Seo TH, Yun HS, Cho HS, Kim BK, Choe WH, Lee CH, Kim JN, Yim HJ. Clinical features of acute hepatitis A in recent two years clinical features of acute hepatitis A in recent two years. Korean J Gastroenterol. 2008; 52:298–303.
2. Brown GR, Persley K. Hepatitis A epidemic in the elderly. South Med J. 2002; 95:826–833.
3. Franco E, Giambi C, Ialacci R, Coppola RC, Zanetti AR. Risk groups for hepatitis A virus infection. Vaccine. 2003; 21:2224–2233.
4. Jung YK, Kim JH. Epidemiology and clinical features of acute hepatitis A: from the domestic perspective. Korean J Hepatol. 2009; 15:438–445.
5. Kang HM, Jeong SH, Kim JW, Lee D, Choi CK, Park YS, Hwang JH, Kim N, Lee DH. Recent etiology and clinical features of acute viral hepatitis in a single center of Korea. Korean J Hepatol. 2007; 13:495–502.
6. Lee H, Cho HK, Kim JH, Kim KH. Seroepidemiology of hepatitis A in Korea: changes over the past 30 years. J Korean Med Sci. 2011; 26:791–796.
7. Kim JH. Recent epidemiological status and vaccination of hepatitis A in Korea. J Korean Med Assoc. 2008; 51:110–118.
8. Cheong HJ. Vaccination necessary for Korean adults. J Korean Med Assoc. 2011; 54:1289–1296.
9. Baek JH, Kim CO, Park JY, Jeong SJ, Koo NS, Kim HW, Han SH, Choi JY, Song YG, Kim JM. Clinical factors associated with hepatitis A virus seropositivity in HIV-infected adults living in a country with an epidemiologic shift for hepatitis A virus infection. J Korean Med Sci. 2012; 27:969–971.
10. Chung GE, Yim JY, Kim D, Lim SH, Park MJ, Kim YS, Yang SY, Yang JI, Cho SH. Seroprevalence of hepatitis a and associated socioeconomic factors in young healthy Korean adults. Gut Liver. 2011; 5:88–92.
11. Choi HK, Song YG, Kim CO, Shin SY, Chin BS, Han SH, Jin SJ, Chae YT, Baek JH, Kim SB, et al. Clinical features of re-emerging hepatitis A: an analysis of patients hospitalized during an urban epidemic in Korea. Yonsei Med J. 2011; 52:686–691.
12. Askling HH, Rombo L, Andersson Y, Martin S, Ekdahl K. Hepatitis A risk in travelers. J Travel Med. 2009; 16:233–238.
13. Jacobsen KH, Koopman JS. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int J Epidemiol. 2005; 34:600–609.
14. Roberts RJ, Palmer SR. Exposure to school children as a risk factor in a community outbreak of hepatitis A in young adults: a case control study. Epidemiol Infect. 2006; 134:803–807.
15. Roy K, Howie H, Sweeney C, Parry J, Molyneaux P, Goldberg D, Taylor A. Hepatitis A virus and injecting drug misuse in Aberdeen, Scotland: a casecontrol study. J Viral Hepat. 2004; 11:277–282.
16. Yoon YK, Chun BC, Lee HK, Seo YS, Shin JH, Hong YS, Sim HS, Kim JY, Kim JY, Park YS, et al. Epidemiological and genetic analysis of a sustained community-wide outbreak of hepatitis A in the Republic of Korea, 2008: a hospital-based case-control study. J Clin Virol. 2009; 46:184–188.
17. Mohd Hanafiah K, Jacobsen KH, Wiersma ST. Challenges to mapping the health risk of hepatitis A virus infection. Int J Health Geogr. 2011; 10:57.
18. Seo JY, Seo JH, Kim MH, Ki M, Park HS, Choi BY. Pattern of hepatitis a incidence according to area characteristics using national health insurance data. J Prev Med Public Health. 2012; 45:164–173.
19. Lee D, Ki M, Lee A, Lee KR, Park HB, Kim CS, Yoon BY, Kim JH, Lee YS, Jeong SH. A nationwide seroprevalence of total antibody to hepatitis A virus from 2005 to 2009: age and area-adjusted prevalence rates. Korean J Hepatol. 2011; 17:44–50.
20. Tsou TP, Liu CC, Huang JJ, Tsai KJ, Chang HF. Change in hepatitis A epidemiology after vaccinating high risk children in Taiwan, 1995-2008. Vaccine. 2011; 29:2956–2961.
21. Kaya D, Guler E, Ekerbicer HC, Dilber C, Karabiber H, Guler S, Davutoglu M, Ciragil P. Hepatitis A seroprevalence and its relationship with environmental factors in children of different age groups in Kahramanmaras, Eastern Mediterranean region of Turkey. J Viral Hepat. 2007; 14:830–834.
22. Ceran N, Yüksel Kocdogan F, Mert D, Erdem I, Dede B, Adaleti R, Ozyürek S, Karagül E, Göktaş P. Hepatitis A seroprevalence in children and young adults in Istanbul, Turkey: seroprevalence change and associated factors. J Viral Hepat. 2012; 19:72–76.
23. De Alencar Ximenes RA, Martelli CM, Merchán-Hamann E, Montarroyos UR, Braga MC, de Lima ML, Cardoso MR, Turchi MD, Costa MA, de Alencar LC, et al. Multilevel analysis of hepatitis A infection in children and adolescents: a household survey in the Northeast and Centralwest regions of Brazil. Int J Epidemiol. 2008; 37:852–861.
24. Venczel L, Brown S, Frumkin H, Simmonds-Diaz J, Deitchman S, Bell BP. Prevalence of hepatitis A virus infection among sewage workers in Georgia. Am J Ind Med. 2003; 43:172–178.
25. Verhoef L, Boot HJ, Koopmans M, Mollema L, Van Der Klis F, Reimerink J, Van Pelt W. Changing risk profile of hepatitis A in the Netherlands: a comparison of seroprevalence in 1995-1996 and 2006-2007. Epidemiol Infect. 2011; 139:1172–1180.
26. Tosti ME, Spada E, Romanò L, Zanetti A, Mele A. SEIEVA collaborating group. Acute hepatitis A in Italy: incidence, risk factors and preventive measures. J Viral Hepat. 2008; 15:26–32.
27. Tsai CF, Lin DB, Chen SC, Chang YH, Chen CY, Lin JB. Seroepidemiology of hepatitis A virus infection among schoolchildren in Taiwan. J Med Virol. 2011; 83:196–200.
28. Byun JM, Kim SG, Zhang YY, Kim YS, Jeong SW, Lee SH, Jang JY, Hong SJ, Moon JH, Kim HS, et al. Influenza A (H1N1) 2009 pandemic calm down the prevalence of acute hepatitis A in the latter half of 2009: Korean Population Study. Korean J Gastroenterol. 2012; 59:360–365.